MMIT Network

The healthcare landscape is always evolving, but MMIT’s mission stays the same: We’re dedicated to helping clients solve their market access challenges. Learn more: ow.ly/BcC150Vl0vp

vist.ly/4yhsx | Payers don’t always respond to a brand’s differentiators as expected. In this study, learn how MMIT’s Message Monitor helped one biopharma company realize that payers were unimpressed with its clinical data, despite its brand’s novel MoA. Download now.

Coverage checks shouldn’t slow care. Discover how MMIT’s BPG Connected Intelligence enables quicker, more accurate benefit verification for clinicians. vist.ly/4ydk4.

Rebate pass-throughs will change how PBMs are paid, which will also change their incentives. MMIT’s Steve Callahan explains why PBMs are likely to embrace private-label manufacturing and extensive contracting. vist.ly/4yaej pharmexec.com/view/new-feder…

When an HIT company sought to simplify benefit verification for physicians using its platform, it turned to MMIT. vist.ly/4xz4q Now, clinicians can quickly surface plan-level coverage details for any patient and any drug, without wasting time.

Coverage shouldn’t feel like detective work. 🕵️ By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions. Illuminate your path with MMIT today. vist.ly/4xvz2

In PharmaExec, MMIT’s Steve Callahan argues that such legislation will lead to tighter utilization management, including more complex prior authorizations, double-step therapy, and conditional formulary access. vist.ly/4xuwt. pharmexec.com/view/new-feder…

For specialty pharmacies, time is not just money—it’s patient care. Ease your patients’ minds with immediate, hassle-free benefit verification. Check out this infographic to see how it works: vist.ly/4xujf

MMIT’s 2025 State of Patient Access report is a finalist in the PPA Awards (@PPA_Live). Insights from 200+ pharma executives show how access evolves. Congrats to Steve Callahan, Hannah Baxter, Izabela Chmielewska & Kelly Mullin. Check out the report: vist.ly/4xjj5

vist.ly/4xevg | Payers don’t always respond to a brand’s differentiators as expected. In this study, learn how MMIT’s Message Monitor helped one biopharma company realize that payers were unimpressed with its clinical data, despite its brand’s novel MoA. Download now.

vist.ly/4x8sh | IT’s Payer Communication Program delivers custom reimbursement and coding updates to more than 80% of payers, as well as additional groups of providers, IDNs, and more. Read the case study for one pharma company’s story.

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside? With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights. Learn more: vist.ly/4x4qx

Coverage shouldn’t feel like detective work. 🕵️ By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions. Illuminate your path with MMIT today. vist.ly/4wtfy

Coverage checks shouldn't be so complicated. Save your pharmacists' time with automatic confirmation of a patient’s benefits, coverage details, and copay for a new prescription. See the infographic: vist.ly/4wt7c

Before prescribing high-cost specialty therapies, coverage clarity matters. See how a healthcare IT company streamlined benefit verification with MMIT’s BPG Connected Intelligence. vist.ly/4wrxz.

Our 2025 State of Patient Access report is a finalist in the @PPA_Live Awards. It examines how market access is changing for patients. Congrats to Steve Callahan, Hannah Baxter, Izabela Chmielewska, and Kelly Mullin. Check out the report here: vist.ly/4wme4

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside? With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights. Learn more: vist.ly/4wgj2

Proud moment of cross-company collaboration: our State of Patient Access 2025 report is a finalist for the PPAAwards 2026 Data Initiative of the Year. Thanks to authors Izabela Chmielewska, Hannah Baxter, Steve Callahan, and designer Kelly Mullin.

Coverage shouldn’t feel like detective work. 🕵️ By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions. Illuminate your path with MMIT today. vist.ly/4vrag

Within a month, one pharma company’s therapy had an updated label and a new HCPCS code. Read the case study to see how MMIT helped the company capitalize on this momentum and share these changes with payers and providers. vist.ly/4vmec

Understanding the patient journey is getting more complex. Machine learning and natural language processing are helping make it clearer. vist.ly/4vmea In our latest ebook, we’re sharing real stories about how MMIT and NorstellaLinQ help pharma manufacturers understand the patient journey quicker and improve market access strategies. Read now to see how ML and NLP clarify the patient journey.